PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid

Biomaterials

Volumn 31, Issue 12, 2010, Pages 3395-3403

  Bondioli, Lucia ^a   Costantino, Luca ^a   Ballestrazzi, Antonio ^a   Lucchesi, Davide ^b   Boraschi, Diana ^b   Pellati, Federica ^a   Benvenuti, Stefania ^a   Tosi, Giovanni ^a   Vandelli, Maria A ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b CNR   (Italy)

Author keywords

Monocyte; Nanoparticle; Poly(lactic co glycolic)acid; Surface modification

Indexed keywords

ANTI-VIRAL EFFECTS; BIOPHARMACEUTICAL PROTEINS; CANCER CELLS; CARBOXYLIC GROUP; CELL SURFACES; DERIVATIZATION OF; DIFFERENT MECHANISMS; HUMAN MONOCYTES; HYDROPHILIC MOIETIES; IN-VITRO ASSAYS; LIVING CELL; MACROMOLECULAR COMPOUNDS; N-ACETYLNEURAMINIC ACID; PLGA NANOPARTICLES; POLY LACTIC-CO-GLYCOLIC ACID; POLY(D ,L-LACTIDE-CO- GLYCOLIDE); SIALIC ACIDS; STARTING MATERIALS; SURFACE MODIFICATION; WHEAT GERM AGGLUTININ;

BODY FLUIDS; CARBOHYDRATES; CARBOXYLIC ACIDS; CELL MEMBRANES; NANOPARTICLES; ORGANIC POLYMERS; SURFACE TREATMENT;

ACIDS;

N ACETYLNEURAMINIC ACID; NANOPARTICLE; POLOXAMER; POLYGLACTIN; POLYSORBATE 80; SIALIC ACID; WHEAT GERM AGGLUTININ;

ARTICLE; COVALENT BOND; DERIVATIZATION; DRUG STRUCTURE; HYDROPHILICITY; IN VITRO STUDY; LIPOPHILICITY; MONOCYTE; PARTICLE SIZE; PHAGOCYTOSIS; PRIORITY JOURNAL; SURFACE PROPERTY; X RAY PHOTOELECTRON SPECTROSCOPY; ZETA POTENTIAL;

HUMANS; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; N-ACETYLNEURAMINIC ACID; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; SPECTRUM ANALYSIS;

TRITICUM AESTIVUM;

EID: 76749159733     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.01.049     Document Type: Article

References (42)

1. Murrey H.E., and Hsieh-Wilson L.C. Sialic acid: the chemical neurobiology of carbohydrates. Chem Rev 108 (2008) 1708-1731
2. DeNinno M.P. The synthesis and glycosidation of N-acetylneuraminic acid. Synthesis (1991) 583-593
3. Byrne B., Donohoe G., and O'Kennedy R. Sialic acids: carbohydrate moieties that influence the biological and physical properties of biopharmaceutical proteins and living cells. Drug Discov Today 12 (2007) 319-326
4. Gregoriadis G., Jain S., Papaioannou I., and Laing P. Improving the therapeutic efficacy of peptides and proteins: a role for polysialic acids. Int J Pharm 300 (2005) 125-130
5. Ishida T., Ichihara M., Wang X., and Kiwada R. Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes. J Control Release 115 (2006) 243-250
6. Immordino M.L., Dosio F., and Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomed 1 (2006) 297-315
7. Moghimi S.M., Hunter A.C., and Murray J.C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53 (2001) 283-318
8. Kato E., Taguchi A., Sakashita S., Akiyoshi K., and Sunamoto J. Synthesis and function of sialic acid-conjugated cholesterols as ganglioside analogs: their reconstitution to liposomes and interaction with rat lymphocytes. Proc Jpn Acad Ser B Phys Biol Sci 76 (2000) 63-67
9. Zanini D., and Roy R. Synthesis of new α-thiosialodendrimers and their binding properties to the sialic acid specific lectin from Limax flavus. J Am Chem Soc 119 (1997) 2088-2095
10. Sakamoto J.I., Koyama T., Miyamoto D., Yingsakmongkon S., Hidari K.I.P.J., Jampangern W., et al. Systematic syntheses of influenza neuraminidase inhibitors: a series of carbosilane dendrimers uniformly functionalized with thioglycoside-type sialic acid moieties. Bioorg Med Chem 17 (2009) 5451-5464
11. Marra A., Moni L., Pazzi D., Corallini A., Bridi D., and Dondoni A. Synthesis of sialoclusters appended to calyx[4]arene platforms via multiple azide-alkyne cycloaddition. New inhibitors of hemagglutination and cytopathic effect mediated by BK and influenza A viruses. Org Biomol Chem 6 (2008) 1396-1409
12. Gamian A., Chomik M., Laferriere C.A., and Roy R. Inhibition of Influenza A virus hemagglutinin and induction of interferon by synthetic sialylated glycoconjugates. Can J Microbiol 37 (1991) 233-237
13. Mammen M., Dahmann G., and Whitesides G.M. Effective inhibitors of hemagglutination by influenza virus synthesized from polymers having active ester groups. Insight into mechanism of inhibition. J Med Chem 38 (1995) 4179-4190
14. Furuike T., Aiba S., Suzuki T., Takahashi T., Suzuki Y., Yamada K., et al. Synthesis and anti-influenza virus activity of novel glycopolymers having triantennary oligosaccharide branches. J Chem Soc Perkin Trans (2000) 3000-3005
15. Suzuki K., Sakamoto J.I., Koyama T., Yingsakmongkon S., Suzuki Y., Hatano K., et al. Synthesis of sialic acid derivatives having a C{double bond, long}C double bond substituted at the C-5 position and their glycopolymers. Bioorg Med Chem Lett 19 (2009) 5105-5108
16. Tsuchida A., Kobayashi K., Matsubara N., Muramatsu T., Suzuki T., and Suzuki Y. Simple synthesis of sialyllactose-carrying polystyrene and its binding with influenza virus. Glycoconj J 15 (1998) 1047-1054
17. Totani K., Kubota T., Kuroda T., Murata T., Hidari K.I.P.J., Suzuki T., et al. Chemoenzymatic synthesis and application of glycopolymers containing multivalent sialyloligosaccharides with a poly(l-glutamic acid) backbone for inhibition of infection by influenza viruses. Glycobiology 13 (2003) 315-326
18. Ogata M., Murata T., Murakami K., Suzuki T., Hidari K.I.P.J., Suzuki Y., et al. Chemoenzymatic synthesis of artificial glycopeptides containing multivalent sialyloligosaccharides with a γ-polyglutamic acid backbone and their effect on inhibition of infection by influenza viruses. Bioorg Med Chem 15 (2007) 1383-1393
19. Umemura M., Itoh M., Makimura Y., Yamazaki K., Umekawa M., Masui A., et al. Design of a sialylglycopolymer with a chitosan backbone having efficient inhibitory activity against influenza virus infection. J Med Chem 51 (2008) 4496-4503
20. Jayant S., Khandare J.J., Wang Y., Singh A.P., Vorsa N., and Minko T. Targeted sialic acid-Doxorubicin Prodrugs for intracellular delivery and cancer treatment. Pharm Res 24 (2007) 2120-2130
21. Uhrich K.E., Cannizzaro S.M., Langer R.S., and Shakesheff K.M. Polymeric systems for controlled drug release. Chem Rev 99 (1999) 3181-3198
22. Dechy-Cabaret O., Martin-Vaca B., and Bourissou D. Controlled ring-opening polymerization of lactide and glycolide. Chem Rev 104 (2004) 6147-6176
23. Panagi Z., Beletsi A., Evangelatos G., Livianiou E., Ithakissios D.S., and Avgoustakis K. Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles. Int J Pharm 221 (2001) 143-152
24. Suzuki Y., Sato K., Kiso M., and Hasegawa A. New ganglioside analogs that inhibit influenza virus sialidase. Glycoconj J 7 (1990) 349-356
25. Halder K.K., Mandal B., Debnath M.C., Bera H., Ghosh L.K., and Gupta B.K. Chloramphenicol-incorporated poly lactide-co-glycolide (PLGA) nanoparticles: formulation, characterization, technetium-99m labelling and biodistribution studies. J Drug Target 16 (2008) 311-320
26. Sashiwa H., Makimura Y., Shigemasa Y., and Roy R. Chemical modification of chitosan: preparation of chitosan-sialic acid branched polysaccharide hybrids. Chem Commun (2000) 909-910
27. Kuhn R., Lutz P., and MacDonald D.L. Synthese anomerer sialinsaure-methylketoside. Chem Ber 99 (1966) 611-617
28. Hasegawa A., Nakamura J., and Kiso M. Studies on the thioglycosides of N-acetylneuraminic acid 1: synthesis of alkyl a-glycosides of 2-thio-N-acetylneuraminic acid. J Carbohydr Chem 5 (1986) 11-19
29. Marra A., and Sinay P. Stereoselective synthesis of 2-thioglycosides of N-acetylneuraminic acid. Carbohydr Res 187 (1989) 35-42
30. Ciccotosto S., Kiefel M.J., Abo S., Stewart W., Quelch K., and von Itzstein M. Synthesis and evaluation of N-acetylneuraminic acid-based affinity matrices for the purification of sialic acid-recognizing proteins. Glycoconj J 15 (1998) 663-669
31. Nguyen T., and Francis M.B. Practical synthetic route to functionalized rhodamine dyes. Org Lett 5 (2003) 3245-3248
32. Fessi H., Puisieux F., Devissaguet J.P., Ammoury N., and Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm 55 (1989) R1-R4
33. Sussman E.M., Clarke M.B., and Shastri P. Single-step process to produce surface-functionalized polymeric nanoparticles. Langmuir 23 (2007) 12275-12279
34. Dong Y., and Feng S.S. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 25 (2004) 2843-2849
35. Kiss E., Bertoti I., and Vargha-Butler E.I. XPS and wettability characterization of modified poly(lactic acid) and poly(lactic/glycolic acid) films. J Colloid Interface Sci 245 (2002) 91-98
36. Leadley S.R., Davies M.C., Vert M., Braud C., Paul A.J., Shard A.G., et al. Probing the surface chemical structure of the novel biodegradable polymer poly(β-malic acid) and its ester derivatives using ToF-SIMS and XPS. Macromolecules 30 (1997) 6920-6928
37. Zhang Z., and Feng S.S. In vitro investigation on poly(lactide)-Tween 80 copolymer nanoparticles fabricated by dialysis method for chemotherapy. Biomacromolecules 7 (2006) 1139-1146
38. Craparo E.F., Ognibene M.C., Casaletto M.P., Pitarresi G., Teresi G., and Giammona G. Biocompatible polymeric micelles with Polysorbate 80 for use in brain targeting. Nanotechnology 19 (2008) 485603
39. Rensen P.C.N., Van Leeuwen S.H., Sliedregt L.A.J.M., van Berkel T.J.C., and Biessen E.A.L. Design and synthesis of novel N-acetylgalactosamine-terminated glycolipids for targeting of lipoproteins to the hepatic asialoglycoprotein receptor. J Med Chem 47 (2004) 5798-5808
40. Lemarchand C., Gref R., and Couvreur P. Polysaccharide-decorated nanoparticles. Eur J Pharm Biopharm 58 (2004) 327-341
41. Owens D.E., and Peppas N.A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307 (2006) 93-102
42. Moghimi S.M., and Szebeni J. Stealthy liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 42 (2003) 463-478